Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.26 AUD | +1.22% | +1.92% | +3.19% |
02/04 | Morgans Financial Downgrades ALS to Hold from Add, Price Target at AU$13.70 | MT |
26/03 | Jarden Adjusts ALS's Price Target to AU$13.70 from AU$13.80, Keeps at Buy | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.19% | 4.19B | |
+15.98% | 70.64B | |
+7.79% | 17.5B | |
+22.52% | 13.88B | |
+16.13% | 13.34B | |
+17.99% | 10.2B | |
-22.19% | 6.47B | |
-1.57% | 5.78B | |
+0.30% | 5.11B | |
-0.65% | 4.96B |
- Stock Market
- Equities
- ALQ Stock
- News ALS Limited
- Transcript : ALS Limited, Nuvisan Pharma Holding Gmbh - M&A Call